Rituximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, By Application, By Route of Administration, By Molecule Type, By Distribution Channel Region And Segment Forecasts, 2025-2034
Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia and non-Hodgkin’s lymphoma, as well as an autoimmune disorder such as Rheumatoid arthritis. Rituximab i...
Report ID: 1081 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Synthetic Lethality-based Drugs and Targets Market Size, Share & Trends Analysis Report By Type (Monotherapy, Combination Therapy), By Application (Medical Research Institution, Hospital and Clinic), By Region, And By Segment Forecasts, 2025-2034
Synthetic Lethality-based Drugs and Targets Market Size is predicted to witness a 14.5% CAGR during the forecast period for 2025-2034. Synthetic lethality refers to a genetic and cancer treatment notion in which the simultaneous dysfunction of two genes results in cell death, whereas the dysfunction of either gene alone does not have the same effect. This method is employed to create precise cancer treatments that take advantage of parti...
Report ID: 2657 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Vitamins, Minerals and Supplements CDMO Market Size, Share & Trends Analysis Distribution by Types (Vitamins, Minerals, Dietary Supplements), Dosage Form (Tablets & Capsules, Powder, Softgel), Service Type (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance), Company Size- and Segment Forecasts, 2025-2034
Vitamins, Minerals and Supplements CDMO Market Size is valued at USD 41.74 Bn in 2024 and is predicted to reach USD 97.60 Bn by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034. The Vitamins, Minerals, and Supplements (VMS) Contract Development and Manufacturing Organization (CDMO) market is a rapidly growing segment within the broader nutraceutical industry. VMS CDMOs provide comprehensive services for the development, m...
Report ID: 2669 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 165
Lentiviral Vector (LVV) CDMO Services Market Size, Share & Trends Analysis Report By Service Type (Process Development & Analytical Services, GMP Manufacturing of LVV, Non-GMP / Preclinical LVV Production, Fill–Finish & Packaging Services, Quality, Regulatory & Tech Transfer Services, Integrated End-to-End LVV CDMO Services), By Scale / Manufacturing Stage (Preclinical / Research-Scale Manufacturing, Early Clinical Manufacturing (Phase I / II), Late-Clinical & Commercial-Scale Manufacturing (Phase III / Commercial)), By Application, By End User, By Region, and By Segments Forecast, 2025-2034
Global Lentiviral Vector (LVV) CDMO Services Market Size is predicted to record a 9.0% CAGR during the forecast period for 2025-2034. Lentiviral vectors (LVs) CDMO Services are helpful for gene transfer in mammalian cells because they can efficiently transmit genes from one cell type to another. Lentivirus infections can incubate for a long time and persist for years in animals and humans. The onset of symptoms and initial infection could happen...
Report ID: 2374 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Next Generation Drug Conjugates Market Size, Share & Trends Analysis Report, By Type (Peptide Receptor Radionuclide Therapy, Ligand mediated RNAi Conjugate, Ligand Conjugated Anti Sense Medicine and Peptide Drug Conjugate), By Type of Targeting Ligand (Amino Sugar, Peptide, Lipid, Small Molecule and Virus-like Particles), By Type of Payload (Peptide, Small Molecule, Oligonucleotide, Radionuclide), By Type of Therapy (Monotherapy, Combination Therapy), By Route of Administration, By Target Indications, By Region, Forecasts, 2025-2034
Global Next Generation Drug Conjugates Market Size was valued at USD 2.9 Bn in 2024 and is predicted to reach USD 12.1 Bn by 2034 at a 15.2% CAGR during the forecast period for 2025-2034. The next-generation drug conjugates (NGDCs) market represents a paradigm shift in cancer therapy, leveraging the synergistic potential of targeted drug delivery and enhanced therapeutic efficacy. NGDCs are a class of bioconjugates that combine cytotoxic payload...
Report ID: 2482 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Lipid Nanoparticle Raw Materials Market Size, Share & Trends Analysis Report, By Application (Therapeutics and Research), By Product (Kits, Reagents, Others), By Disease Indication (Cancer, Infectious Diseases, Blood Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Forecasts, 2025-2034
Global Lipid Nanoparticle Raw Materials Market Size was valued at USD 239.4 Mn in 2024 and is predicted to reach USD 421.2 Mn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Lipids, stabilizers, and occasionally targeting ligands make up the different raw elements that make up lipid nanoparticles. Phospholipids, such as phosphatidylcholine and cholesterol, are often utilized lipids. Several important reasons are dr...
Report ID: 2367 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
IVD Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Nanoparticle Formulated (Organic, Inorganic, and Carbon-based Nanoparticles), By Organic Nanoparticle Formulated, By Inorganic Nanoparticle Formulated, By Scale of Operation, Region, And Segment Forecasts, 2025-2034
IVD Contract Manufacturing Market Size is valued at 15.88 billion in 2024 and is predicted to reach 50.50 billion by the year 2034 at a 12.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing occurence of infectious diseases and the need for early diagnosis drive the demand for IVD devices, which in turn drives the growth of the IVD contract manufacturing market. Increasing reg...
Report ID: 1882 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Super Generics Market Size, Share & Trends Analysis Report By Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders and Other Disorders), By Route of Administration (Intravenous, Oral, Subcutaneous and Others), By Type of Molecule (Small and Other Molecules), By Type of Small Molecule (Generics and Other Small Molecules), By Type of Product (Aerosols, Capsules, Prefilled Syringes, Tablets, Vials and Other Products), By Region, And By Segment Forecasts, 2025-2034
Global Super Generics Market Size is valued at USD 77.4 Bn in 2024 and is predicted to reach USD 157.7 Bn by the year 2034 at a 7.5% CAGR during the forecast period for 2025-2034. Super generics, commonly referred to as value-added generics, are improved versions of generic medications. They provide extra benefits above regular generics, such as better efficacy, safety, and convenience of use. Super generics are created using unique formulation ...
Report ID: 2437 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Radioactive Tracer Market Size, Share & Trends Analysis Report By Tracer Type , Test Type (PET, SPECT, Others), Application (Oncology, Pulmonary, Neurology, Cardiology, Others), End User, Region And Segment Forecasts, 2025-2034
Global Radioactive Tracer Market Size is valued at USD 3.5 billion in 2024 and is predicted to reach USD 7.19 billion by the year 2034 at a 7.4% CAGR during the forecast period for 2025-2034. The radioactive tracer is a chemical molecule in which one or more atoms have been replaced with a radionuclide. Radioactive tracers are utilized in imaging studies to assist in diagnosing internal health issues. These tracers emit particles that m...
Report ID: 2042 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Biostatistics Consulting Service Market Size, Share & Trends Analysis Report By Application (Pharmaceutical Company, Medical Device Company, and Others), By Type (Project Management and Data Management), By Region, And By Segment Forecasts, 2025-2034
Global Biostatistics Consulting Service Market Size is predicted to witness a 10.0% CAGR during the forecast period for 2025-2034. Biostatistics is the applied field of statistics for biological, life science, and health-related data. It is utilized by consultants specialising in statistical tools, analysis, study design, data interpretation, medical research, clinical trials, and epidemiological investigations. The rising existance of chronic d...
Report ID: 2318 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Pharmaceuticals